Paperpal Prime Logo

Translational Neurodegeneration : Impact Factor & More

eISSN: 2047-9158pISSN: 2047-9158
JournalOpen Access

Key Metrics

CiteScore
12
Impact Factor
10 - 15
SJR
Q1Neurology (clinical)
SNIP
1.76
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Translational Neurodegeneration

Translational Neurodegeneration Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2490 | USD 2890 | GBP 2090
Publication Time10
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 10
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Translational Neurodegeneration ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Translational Neurodegeneration

Capsaicin suppresses microglial inflammation through TRPV1-SSR4 interaction.
  • 21 Oct 2026
  • Translational neurodegeneration
Exercise promotes lipophagy and mitigates cognitive impairment in Alzheimer\u2019s disease through downregulating microglial TMEM9
  • 19 Oct 2026
  • Translational Neurodegeneration
ProSAAS overexpression arrests progression of motor deficits in a rat alpha-synuclein model of Parkinson\u2019s disease
  • 16 Oct 2026
  • Translational Neurodegeneration
Levetiracetam restores GABAergic function and network homeostasis following Vps35 deficiency in excitatory neurons
  • 14 Oct 2026
  • Translational Neurodegeneration
The glymphatic–lymphatic axis: known pathways, open questions, and emerging roles in neurodegeneration
  • 9 Oct 2026
  • Translational Neurodegeneration
Fyn kinase: a key mechanistic regulator and therapeutic target in tauopathy and neurodegenerative diseases
  • 1 Oct 2026
  • Translational Neurodegeneration
Capsaicin suppresses microglial inflammation through TRPV1-SSR4 interaction.
  • 21 Oct 2026
  • Translational neurodegeneration
Exercise promotes lipophagy and mitigates cognitive impairment in Alzheimer\u2019s disease through downregulating microglial TMEM9
  • 19 Oct 2026
  • Translational Neurodegeneration
ProSAAS overexpression arrests progression of motor deficits in a rat alpha-synuclein model of Parkinson\u2019s disease
  • 16 Oct 2026
  • Translational Neurodegeneration
Levetiracetam restores GABAergic function and network homeostasis following Vps35 deficiency in excitatory neurons
  • 14 Oct 2026
  • Translational Neurodegeneration
The glymphatic–lymphatic axis: known pathways, open questions, and emerging roles in neurodegeneration
  • 9 Oct 2026
  • Translational Neurodegeneration
Fyn kinase: a key mechanistic regulator and therapeutic target in tauopathy and neurodegenerative diseases
  • 1 Oct 2026
  • Translational Neurodegeneration

FAQs on Translational Neurodegeneration